1. Home
  2. WEYS vs PYXS Comparison

WEYS vs PYXS Comparison

Compare WEYS & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$34.18

Market Cap

280.9M

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$1.44

Market Cap

243.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
PYXS
Founded
1906
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.9M
243.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WEYS
PYXS
Price
$34.18
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
17.0K
1.2M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
3.16%
N/A
EPS Growth
N/A
N/A
EPS
2.54
N/A
Revenue
$279,843,000.00
$2,820,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.51
$0.83
52 Week High
$38.24
$5.55

Technical Indicators

Market Signals
Indicator
WEYS
PYXS
Relative Strength Index (RSI) 56.89 21.45
Support Level $33.48 $4.10
Resistance Level $34.44 $4.58
Average True Range (ATR) 1.10 0.39
MACD 0.20 -0.35
Stochastic Oscillator 69.18 0.19

Price Performance

Historical Comparison
WEYS
PYXS

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: